Every patient undergoes a thorough evaluation and receives education, nutritional counseling, and long-term support before and after surgery to promote lasting success
Approved Weight-Loss Options May Already Help Retatrutide is still in trials, but patients can start improving their health now
Individual response varies based on medication formulation, baseline metabolic status, adherence to lifestyle modifications, and gastrointestinal tolerance
This proactive approach can reduce the severity of initial side effects
GLP1-RAs currently available in Canada include semaglutide (Ozempic, Ryblesus, Wegovy), liraglutide (Victoza, Saxenda, Xultophy ), dulaglutide (Trulicity), lixisenatide (Soliqua ) and tirzepatide (Mounjaro, Zepbound)
The process typically takes hours to one business day